These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Family history and pathophysiological mechanisms of primary hypertension. Studies in non-hypertensive young men with positive and negative family histories of hypertension. Widgren BR Scand J Urol Nephrol Suppl; 1991; 134():1-75. PubMed ID: 1887213 [TBL] [Abstract][Full Text] [Related]
4. Peripheral handling of angiotensin II and blood pressure control in hypertensive patients with unilateral and bilateral renal disease. Carpi A; Donato L Contrib Nephrol; 1978; 11():164-9. PubMed ID: 699586 [TBL] [Abstract][Full Text] [Related]
5. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis. Sørensen SS; Danielsen H; Jespersen B; Pedersen EB Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595 [TBL] [Abstract][Full Text] [Related]
6. Effects of brain renin-angiotensin on cardiovascular function and saline intake in awake dogs. Buckley JP; Jandhyala BS; Doursout MF; Huang YK; Chelly JE J Physiol (Paris); 1984; 79(6):485-90. PubMed ID: 6399316 [TBL] [Abstract][Full Text] [Related]
8. Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II and vasopressin. Goldberg JP; Schrier RW Miner Electrolyte Metab; 1984; 10(3):178-83. PubMed ID: 6727804 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis. Yamakado M; Umezu M; Nagano M; Tagawa H Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212 [TBL] [Abstract][Full Text] [Related]
11. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. Brilla CG; Zhou G; Matsubara L; Weber KT J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody. Wong PC; Price WA; Reilly TM; Duncia JV; Timmermans PB J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of microinjection of angiotensin II in the brainstem of renal hypertensive rats. Mosqueda-Garcia R; Tseng CJ; Appalsamy M; Robertson D J Pharmacol Exp Ther; 1990 Oct; 255(1):374-81. PubMed ID: 2213569 [TBL] [Abstract][Full Text] [Related]
14. Blood Pressure Covariance Not Accounted for in Angiotensin II for the Treatment of High-Output Shock 3 Subgroup Analysis. Rascona DA; Roy-Shapira A Crit Care Med; 2019 Mar; 47(3):e270-e271. PubMed ID: 30768521 [No Abstract] [Full Text] [Related]
15. Angiotensin II metabolism and blood pressure in chronic renal disease. Carpi A; Palla R; Puntoni R; Donato L Proc Eur Dial Transplant Assoc; 1976; 12():307-12. PubMed ID: 935122 [TBL] [Abstract][Full Text] [Related]
16. Renal extraction of angiotensin II. Jackson EK; Herzer WA J Pharmacol Exp Ther; 2003 Dec; 307(3):1001-6. PubMed ID: 14534364 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure. Jacobi J; Schlaich MP; Delles C; Schobel HP; Schmieder RE Am J Hypertens; 1999 Apr; 12(4 Pt 1):418-22. PubMed ID: 10232503 [TBL] [Abstract][Full Text] [Related]